The Pharmacy Guild of Australia and the Pharmaceutical Society of Australia have collaborated to develop a range of materials and training resources to support community pharmacy in the transition to the upscheduling of codeine on 1 February 2018.
In November 2017, community pharmacies across Australia were sent a package of materials which were designed to support pharmacists and their patients around the changes. The materials sent out to pharmacies included:
There are some materials still available if your pharmacy is interested in receiving additional copies. Please contact firstname.lastname@example.org
The Guild and PSA also worked together to develop specialised online training modules and tools for pharmacists and pharmacy staff to ensure the transition is as smooth as possible. All the training modules are now available for all pharmacists to access via Guild Learning & Development and the PSA's websites.
Funding for this project was provided by the Australian Government.
The Therapeutic Goods Administration (TGA) has published a list of products that have gone through the upscheduling process. The list includes those previously available over-the-counter (Schedule 2, Schedule 3) codeine-containing products that have been upscheduled to prescription medicine (Schedule 4) via application to the TGA. You should contact the sponsor to confirm their intention to continue marketing their goods in Australia after 1 February 2018.
The TGA advises that products containing other codeine derivatives, such as pholcodine, dextromethorphan and dihydrocodeine are unaffected by the decision to upschedule codeine.
Further information is available through the TGA's codeine information hub.